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How infectious a person is when infected with HIV depends upon what stage
of the disease the person is in. We use three stages which we call primary,
asymptomatic and symptomatic. It is important to have a systematic method for
computing all three infectivities so that the measurements are comparable. Using
robust modeling we provide high-resolution estimates of semen infectivity by HIV
disease stage. We find that the infectivity of the symptomatic stage is far higher,
hence more potent, than the values that prior studies have used when model-
ing HIV transmission dynamics. The stage infectivity rates for semen are 0.024,
0.002, 0.299 for primary, asymptomatic and symptomatic (late-stage) respec-
tively. Implications of our infectivity estimates and modeling for understanding
heterosexual epidemics such as the Sub-Saharan African one are explored.
Most models are compartment models that are based on the number of new
infections per unit time. We create a new risk-based model that focuses on a
susceptible person’s risk of becoming infected if he has a single contact with an
infected individual.
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Chapter 1
Determining Infectiousness of HIV
1.1 Introduction
Our goal is to determine how the infectiousness of semen of HIV infected men
varies by stage of disease. The actual infectiousness will vary from person to
person so we will compute an average. It will also depend on the type of sexual
act, higher for some types than for others. We find that susceptible gay men
involved in unprotected receptive anal intercourse (RAI) are 12.5 times as likely
to become infected when the partner is an infected symptomatic man than when
the partner is in the primary stage; that is, symptomatic men are 12.5 times
as infectious as primary men. Furthermore, asymptomatic-stage men are 149.5
times less infectious than symptomatic men. We expect this general pattern of
infectivity to hold for all sex acts of infected men.
We focus on measuring the infectivity of gay men. By the “infectivity” of
a person, we mean the fraction of his susceptible “contacts” that he infects.
For HIV we interpret a “contact” to be the activity in which most infected gay
men became infected [1, 2]. Infectivity varies as the disease progresses in the
individual, and of course one cannot conduct experiments to determine infectivity.
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In this paper we analyze the San Francisco City Clinic Cohort data, and figure
out how many contacts there are at each point in time between susceptibles
and infecteds, and what stages of infection those men are in. This is not a
straightforward calculation. We take into account the great variability between
the contact rates of the men.
SFFCC Data: The only high-resolution data set documenting the onset of
HIV in a population is the San Francisco City Clinics Cohort (SFCCC) study,
which is based on blood samples from an earlier Hepatitis B Vaccine Clinical
trial that took place during the period in which HIV exploded through the San
Francisco gay population [3, 4, 5] (Table 1.1). That study, involving about 10%
of the San Francisco gay population, involved 6875 men and took both blood
samples and behavioral data. After HIV was identified, stored blood samples
were thawed and tested for the presence of HIV antibodies. This enabled one
to document the growth of HIV through the population (Figure 1.1) and relate
that growth to behavioral data. We stress that with respect to HIV incidence,
that data set is a biological one not dependent on medical diagnosis or infection
self-report [4].
Variable Infectivity: It is widely understood that epidemiological modeling of
HIV transmission must utilize at least three stages (primary infection, asymp-
tomatic, and symptomatic including AIDS) with different infectivities for each
stage (Figure 1.2). First comes a period of primary infection (lasting part of
a year). Our primary infectious stage is defined as the time soon after initial
infection when infectiousness first rises and then drops. Seroconversion, the de-
velopment of antibodies, typically occurs well before the end of our primary
















1979 85.9 9.6 0
1980 73.8 12.1 0.1 0.05
1981 68.6 5.2 0.55 0.32
1982 51.5 17.1 1.72 1.13
1983 39.3 12.2 3.56 2.64
1984 32.6 8.5 5.85 4.7
Table 1.1: SFCCC HIV Onset Data. Susceptible and infected fractions (Columns
2 and 3) for each year (Column 1) are from the published sources (3,4). The per-
cent of the population symptomatic at year-end (Column 4) is derived from the
Figure 1.1 optimized solution of the stage/sub-stage model of HIV transmission.
These show reasonable agreement with 1987 estimates [6] doubled to correct for
the 1993 redefinition of AIDS [7]. The estimated % of the population symp-
tomatic at mid-year (Column 5) is the average of this and the previous year’s
year-end symptomatic fractions.
3
Figure 1.1: Growth of HIV infection through the SFCCC [4] Note the 1980-1981
“lull” wherein the epidemic slows down before explosively restarting the next
near. This phenomenon in the data has not been addressed in the epidemiological
literature modeling the SFCCC epidemic data. (It may be a statistical artifact.)
Our modeling shows that this lull can be reproduced only in variable infectivity
models where late-stage (symptomatic) transmission dominates the epidemic once
about 30% of highly promiscuous populations are infected.
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Figure 1.2: HIV stages [9] and infectiousness. A susceptible becomes newly
infected and progresses from a primary infection stage through an asymptomatic
stage into a symptomatic stage followed by death. Infectiousness varies greatly
from stage to stage.
treatment) in which infectiousness is very low, followed by a symptomatic stage
(averaging three years until death without treatment) where infectiousness rises
again. The symptomatic stage begins while individuals are relatively healthy and
active though it also includes the more severe AIDS phase. These average times
are based on SFCCC data [8].
Viral levels also vary greatly between these three stages. During the period
of primary infection viral levels are typically high. The viral levels become low
as one enters into the asymptomatic period, followed by a symptomatic/AIDS
stage where the viral loads are extremely high [10, 11, 12] (Figure 1.3).
If one assumes, plausibly, that HIV infectivity correlates with semen viral
levels [13, 14, 15, 16] then one would expect that HIV transmission is more
infectious during the primary infection and symptomatic stages than during the
asymptomatic stage and is even more infectious during the symptomatic stage.
Note: Our model does not use information about viral loads, but obtains
results showing that infectivity follows a pattern similar to the viral loads shown
in Figure 1.3.
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Figure 1.3: Variable viral loads over the course of a typical untreated individual’s
HIV infection (source: Reworked from Anderson [13]).
That primary stage plays a significant role in the original gay HIV epidemic
is widely understood due to epidemiological modeling by Jacquez, Koopman,
Hethcote and Van Ark, Ahlgren, Longini, and others [6, 8, 17, 18]. None of these
prior studies attributes a significant role to late-stage symptomatic transmission
in shaping the epidemic. A frequently referenced paper, Jacquez et. al. 1994 [18],
says “a review of the data on infectivity per contact for transmission of the HIV
suggests that the infectivity may be on the order of 0.1 to 0.3 per anal intercourse
in the period of the initial infection, 10−4 to 10−3 in the long asymptomatic
period, and 10−3 to 10−2 in the period leading to AIDS.” They obtained the
primary and asymptomatic-stage infectivities by looking at the initial growth of
the epidemic and determined what infectivities would be necessary to create such
an exponential growth. In contrast to those results that are carefully obtained
via detailed models, they say without giving any details that the symptomatic-
stage infectivity was estimated using previous partner studies [19, 20, 21] and in
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most cases heterosexual partner studies. It is unclear how those stage estimates
were obtained, since those studies do not differentiate infectivity per stage, but
had an “average” infectivity for the course of the disease. We remark that in
[[22], (see Figure 1 page 56)], one can see that there is a negative correlation
between the number of contacts a couple has and the probability that the disease
will be transmitted. For couples with more contacts it was reported less likely
for the susceptible partner to become infected. Ahlgren [8] reported they were
unable to obtain reliable estimates of symptomatic-stage infectivity using data on
reported incidence of AIDS infections. In the early epidemic those data are very
unreliable due to underreporting, mis-diagnosis, and changing definitions of AIDS
in estimating symptomatic-stage infectivities. Our approach relies neither upon
those prior partner-study estimates nor problematic reported AIDS incidence
data.
Activity Levels: The SFCCC reports annual numbers of partners for six dif-
ferent activity levels [6, 8](Table 1.2). The most active half have more than 10
times as many contacts as the lower half. By 1982 almost half the population
was infected, presumably primarily the most active half. The most active 10%
(the “core”) are responsible for nearly half of all sexual contacts [23].
Published survey data gives the distribution of the number of partners for six
activity levels, but does not give receptive anal intercourse (RAI) group averages.
However, the data indicate that for the overall population 57% of the contacts
involved RAI by at least one of the two partners [8, 24], so we estimate RAI
activity for each group at 57% of total activity. Note: If the RAI is for only
one partner then we are over-estimating the number of contacts by a factor of
2, resulting in a 50% underestimation of stage infectivities, but not affecting the
7




1 (”Core”) 10% 231 0.48
2 15% 81 0.25
3 25% 33 0.17
4 25% 15 0.078
5 15% 3 0.009
6 10% 0 0.000
Total Pop 100% 48
Table 1.2: Group RAI Contact Behavior. Group contact data (Columns 1-3) are
from reference [6]. Group fraction of all contacts is the total number of annual
RAI contacts for the group (Column 2 Column 3) divided by the population
average of 48.
ratios of stage infectivities. Thus we divide the population into 6 groups based
on this estimated average RAI activity (= contacts). Average number of RAI
partners per year is 48 [8, 25]. These estimates are Column 3 of Table 1.2.
Most prior (homosexual) studies [8, 12, 26] either did not differentiate activity
groups or else had only two groups, a highly active “core” group consisting of
5-10% of the population and a less active non-core. Models with only one or two
activity groups give results which differ significantly from the six-group model.
Available evidence suggests that unprotected sexual activity did not decrease
significantly until 1985 [27]. For this reason we model the epidemic through 1984
with no behavioral change. We also assume that each individual’s sexual activity
level is the same for all three stages of the infection. We later discuss the effect
8
of modifying these two modeling assumptions.
Mixing Patterns: We model interactions among six activity groups, obtained
from published SFCCC survey data, as if all sexual contacts were casual and
promiscuous–such as was typical in gay bathhouses where contacts are fairly
indiscriminate and casual. Our bathhouse assumption is that gay contacts
resemble bathhouse patterns. More specifically, published SFCCC data gives
average contact rates for six different activity levels. We assume these specify
the average frequency with which persons go to the bathhouse, but once inside
the mixing pattern is random. Thus the bathhouse assumption addresses both
the frequency of contacts and the mixing pattern when contacts occur. Since
the core has nearly half of all contacts, nearly half the men in the bathhouse at
any given time are in the highly active, promiscuous core. Figure 1.4 shows that
there are fewer susceptibles in the bathhouse than in the general population–an
essential fact in understanding the epidemic.
A key to understanding the dynamics of an HIV epidemic is estimating from
population totals how different activity-level groups of uninfected people become
infected (Figure 1.5). Our modeling reveals that very early in the epidemic the
core group [28] rapidly becomes infected. The infection spreads through other
groups more slowly. Core members are responsible for 48.5% of all sexual contacts
(Table 1.2). Once most of the core is infected, new infections predominantly are
of group 2 men until they too are mostly infected. Then most new infections will
be of group 3 men, and so on (Figure 1.5).
Infectivity Estimates: The only transmission vector for homosexual trans-
mission of HIV to be shown epidemiologically significant is via receptive anal
intercourse (RAI) [29]. It is standard to interpret HIV infectivities for gay men
9
Figure 1.4: Susceptibles in more active groups are soon depleted. An essential
finding of the distribution problem solution is that there are fewer susceptibles in
the bathhouse than the general population and even fewer members of the most
active groups present in the bathhouse will be susceptible. For example, if 60%
of the population is susceptible (as was the case in mid-1982), we can conclude
that 23% of the men in the bathhouse are susceptible and virtually none of the
Core members present will be susceptible.
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Figure 1.5: Fraction of Infecteds in the Bathhouse by Activity Group: The sus-
ceptible fraction of the entire population over time has been partitioned into
susceptible fractions for each of six different activity groups over time. Our
“bathhouse” assumption is that men vary greatly in how often they make them-
selves available for sex, that is “choose partners in the bathhouse,” but once inside
the bathhouse the choice of partner is rather indiscriminate and every suscepti-
ble man’s per-contact chances of becoming infected are equal. In the bathhouse
susceptibles are similarly determined. More active persons usually get infected
sooner than less active persons. The susceptibles for more active groups drop
faster than in less active groups. The graph shows (along with Figure 1.4), for
example, that when total population susceptibles dropped to 46% (in mid-1983),
only 12% of men in the bathhouse were susceptible and virtually none of the core
were. Method: Model Equation, see Appendix A
11
as RAI infectivities. Early studies that did not consider difference in contact rates
and did not estimate different infectivities for the three stages came up with a
1% infectivity for RAI. It is not unreasonable to construe these estimates as the
average infectivity of an individual over the course of his HIV infection (i.e., as
the average of the stage infectivities weighted by stage durations).
Stage Transitions: It is well established that, in the first approximation, a
typical untreated HIV infection progresses through the stages defined by succes-
sively high, low, and then very high viral levels in the blood1. For the SFCCC
the average durations of each stage are well documented and confirmed by mod-
eling [8]. The problem is that those averages are based on some people who pass
through stages to AIDS faster and others who pass through slower or perhaps
never become symptomatic or develop AIDS. This is only an issue for the rela-
tively long asymptomatic and symptomatic AIDS stages. A good model needs to
have some sort of diffusion pattern producing different rates of passage through
those stages. Since there are no data regarding such “diffusion”, the simplest way
to model this is to allow sub-stages where the number of sub-stages determines
the diffusion gradient. Then one can choose how many sub-stages to use depend-
ing on accuracy of best fit to HIV incidence with different numbers of sub-stages.
Our basic model does this, and does come up with three diffusion sub-stages for
the asymptomatic period and one stage for symptomatic/AIDS (Figure 1.6).
1Individuals undergoing anti-retroviral treatment (ART) tend to progress to AIDS at a much
slower rate than untreated individual[30].
12
Figure 1.6: Schematic representation of model used for optimized fits to SFCCC
epidemic. Three sub-stages have been added to the asymptomatic stage in Figure
1.2. These sub-stages adjust the standard deviation of the mean time spent in
that relatively long stage. Method: Choice of three sub-stages was determined
by optimization studies.
1.2 The Basic Model
Our basic modeling principle is that the constants in our model should be based
on epidemiological data. We avoid a priori assumptions not supported directly
or indirectly by data.
The Stage Model: For primary infection the sub-stages amount to the as-
sumption that the average time after infection that one infects is a quarter of a
year. The peak of the viral load occurs at one quarter of a year [13].
We assume that susceptibles are in three-month cohorts moving through sus-
ceptible and HIV-infection stages as determined by the following variables and
equations where i, j = Activity groups 1 (core), 2, ..., 6; k = Primary, Asymp-
tomatic, Symptomatic (AIDS); and t = 1, 2, 3, ... We assume primary infection
lasts two time periods but that all primary-stage transmission occurs at the end
of the first time period, i.e., 1/4 year. We assume that new susceptibles enter the
population at the same rate at which there are AIDS deaths. We now define the
variables used in our model.
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Susceptible fraction of group i at time t: Si
t
Primary first fraction of group i at time t: P1,i
t
Primary second fraction of group i at time t: P2,i
t
Asymptomatic first fraction of group i at time t: L1,i
t
Asymptomatic second fraction of group i at time t: L2,i
t
Asymptomatic third fraction of group i at time t: L3,i
t
Symptomatic fraction of group i at time t: Ai
t
Death fraction of group i at time t: Di
t
Partnering Rate of group i with group j: rij
Infectivity of persons in group j at stage k: ajk
Fraction of group j that is in stage k at time t: fj,k
t
Duration of Asymptomatic sub-stage (7/3): d
Time step (in terms of fraction of a year): ∆t































































New group i Susceptible fraction:
Si
t+1 = Si
t − P1,it+1 + Dit+1 (1.8)
From this model we can derive:












Model parameters: Most model parameter values are specified using SFCCC
data: Average time from seroconversion (development of antibodies) to death
reportedly was 10.3 years [8]. In our model, the average primary infectious period
lasts for 1/2 year although seroconversion typically occurs at around 3 months.
When we tried shorter primary-stage periods such as 1/3 year we were unable to
fit the data as well. The epidemic behaves as if semen remains infectious for a
bit longer than the usual primary-stage period. Thus the average duration of an
HIV infection is 10.5 years. The remaining parameters are determined by best-fit
approximation to the 1978-1984 SFCCC HIV infection growth data. Thus every
parameter value in the stage model is either a firm SFCCC datum or is highly
15
constrained by the SFCCC data. No unconstrained parameter assumptions are
employed.
Interpreting the Stage Model: The San Francisco population is divided into
6 activity groups and each group is divided into 3 stages of infection (primary,
asymptomatic and symptomatic). To run our model, the user specifies the frac-
tion of the men in each stage at an initial time t0, and the three infectivities for
the three stages of infection.
Given the fraction of each activity group that is in each stage at time t, the
rules built into the model dictate what the corresponding fractions will be at time
t + ∆t, where ∆t is a specified fraction of a year. We typically took ∆t to be 1/4
or 1/3 year for the time step, and we report results here for 1/4 year though the
results for 1/3 are similar. The model takes these fractions and takes another
time step, applying the same procedure to get the corresponding fractions for
time t + 2∆t. The model takes a certain specified number of steps that is long
enough for it to create a record of an outbreak similar to San Francisco’s. For a
detailed description of the model’s bookkeeping see Appendix B.
Initializing the model: We do not know when the epidemic actually began in
San Francisco. Nor do we know the initial state. Nor does it matter. No matter
how we initialize the outbreak (whether the initial man or men are highly active
or less active or in primary stage or symptomatic stage) we must choose an initial
time so that the epidemic reaches the prevalence (i.e., the fraction infected) of
4.5% in 1978, the time of the first prevalence report. By that time and there after,
the distribution of infected people is essentially independent of how we started
the epidemic. As long as the initial infected fraction is small, the long-term shape
of the plot of prevalence is not affected. The first prevalence report from SFCCC
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was 4.5% in 1978.
1.3 Determining the “best-fit” Infectivities
Obtaining “best-fit” infectivities for the three stages: Estimates of average infec-
tiousness for each of the three stages are obtained using the Figure 1.6 model and
our model equations. For any choice of the three infectivities the model can be
run, and an epidemic is produced. In particular the cumulative fraction infected
is reported for each of the seven years from 1978 to 1984. For each of the seven
years we compute the square of the difference between this model epidemic and










We use a minimization technique to select the choice of infectivities for which
the RMS is minimized [4, 13, 31]. We take the gradient of the (RMSError)2 and
use Newton’s method to find a 0 of the vector field. The minimum is obtained for
stage infectivity rates approximately 0.024, 0.002, and 0.299 respectively with an
RMS of 0.016 (Figure 1.7). We call these infectivity estimates the “best-fit infec-
tivities”. The model solution displayed in Figure 1.7 reproduces the “cumulative
SFCCC epidemic” using these best-fit infectivities.
The epidemic for the best-fit infectivities: Figure 1.8 shows that before 1980
about 98% of the infections were caused by primary-stage men who only have
been infected for a few months2. By 1981 this fast transmission wave ends when
2We can understand much of the early dynamics without finding a solution to the model.
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Figure 1.7: Best-Fit Epidemic: The best-fit epidemic is produced by running our
model with the best-fit infectivities (0.024, 0.002, 0.299). This produces an RMS
error of 0.016.
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most of the highly active men are infected and are in the asymptomatic stage.
After 1981, these men begin entering the symptomatic stage and cause most of
the new cases. This second wave is a slow transmission wave where the infectors
are mostly symptomatic men who have been infected for years and are now highly
infectious. The 1980-81 lull [3], shown in Figure 1.1, if not an artifact, is consistent
with low infectivity for asymptomatic men. Symptomatic men are more than 12
times as infectious as primary-stage men for perhaps four times as long, making
the gay slow-transmission wave extremely lethal. Figures 1.8 and 1.9 reveal the
epidemic’s structure: It is the combined effects of the displayed fast-transmission
wave before 1980 followed by the displayed slow-transmission wave.
1.4 Implications of Infectivity Estimates
The infectiousness of semen: Our goal has been to determine how HIV transmission-
infectivity varies as the infection progresses within a typical individual not re-
ceiving medical treatment, using available data. We conclude symptomatic-stage
individuals are about 12.5 (i.e., 0.299/0.024) times more infectious (per contact)
than primary-stage men and about 149.5 (i.e., 0.299/0.002) times more infec-
Of course any active man could have got infected and then infected others, but it is instructive
to focus on the core and only the infections they caused when in the primary stage. Those
men had 231 partners per year or about 115 in the primary stage (1/2 of a year). 48% of those
contacts (or 55 contacts) are with core men. The primary-stage infectivity is 2.4% resulting in
1.3 infections. Some of these infections are in the first quarter year and some in the second and
the average time to infection is 1/4 year. Hence, each quarter of a year the number of infected
men grows by a factor of 1.3. The result of 4 such steps (1 year’s worth) is a growth of a factor
of 3. We see then that the core primary-stage men in San Francisco were able to drive the first
(fast) wave of the epidemic.
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Figure 1.8: The solid curve shows increase of symptomatic men in the bathhouse
where transmission takes place. Symptomatics do not become a significant pres-
ence in the bathhouse until 1981 when 31% of the population had been infected
in the fast wave. Average “infectiousness,” the dashed line, is the percent of sus-
ceptibles infected by a contact with an infected man in the bathhouse (labeled
as “new cases per Susceptible-Infected contact”). Early in the epidemic, when
most transmissions are from primary-stage men, infectiousness is 1%. Later in
the epidemic, during the slow transmission wave, infectiousness triples as men
in symptomatic stage begin transmitting HIV. Since they are a small fraction of
the infected men in the bathhouse, their average infectiousness must be at least
17%-28%. Methods: Based on model equations.
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Figure 1.9: Two-wave Gay Epidemic: Primary stage per-contact infectivity is
1.9%, asymptomatic 0.2%, and symptomatic 30%. The model has solutions that
closely approximate the SFCCC incidence data only when the infectivities are
close to these infectivity levels. Primary-stage men drive the fast-transmission
wave; symptomatic men dominate the slow-transmission wave. Methods: Based
on model equation.
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tious than asymptomatic-stage men. We interpret the infectivities more loosely
as measures of the infectiousness of semen in the three stages. Doing so enables
us to apply our infectivity estimates to heterosexual transmission. Specifically,
we would expect rather similar ratios for the stage probabilities of men infecting
women contacts. The actual stage infectivities for vaginal intercourse might be
higher or lower, depending on the type of contact, but the effective stage ratios
would be similar. We have no way to measure the corresponding infectiousness
of women. In modeling heterosexual populations, we assume that these effective
contact ratios are similar for men and women and apply equally across stages 3.
Effective contact rates for the stages: Now we take into account the duration
of the stage. If all the partners of a man were susceptible, then for each contact
per year the number of men we would expect him to infect is the product of
infectivity and duration. It is 0.012 men (= 0.024 ∗ 1/2) for primary-stage men,
0.014 (= 0.002 ∗ 7) for asymptomatic, and 0.897 (= 0.299 ∗ 3) for symptomatic-
stage men. We call these the “effective contact rates for the stages”. These
numbers measure the relative danger of the three stages to all their susceptible
partners. The effective contact rate for the symptomatic stage is 75 times that
of the primary stage (= 0.897/0.012) and about 64 (= 0.897/0.014) times that
of the asymptomatic stage. Hence if the great majority of a man’s partners are
susceptible, then during the symptomatic stage, he is likely to infect 75 times as
many partners as when he is in the primary stage and 64 times as many as in the
latent stage. That does not mean the primary period is unimportant, since in San
3Studies of heterosexual populations show that untreated infected individuals viral loads
follow a pattern of moderate, then low, then high as a person progresses through the disease
[32, 33, 34, 35]. This corresponds to the pattern of our infectivity estimates.
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Francisco primary contacts were the main method of transmission, up through
1980. It instead suggests how truly dangerous the symptomatic stage is.
If an average infected man contacts N susceptibles per year, over the course of
his infection he will contact 10.5N, since the average duration of infection is 10.5
years. Furthermore, he will infect 0.923N men over the course of his infection,
where 0.923 is the sum of the effective contact rates from above (0.012 + 0.014 +
0.897). We calculate the fraction of the people infected by each stage as follows:
P1 = 0.012/0.923 = 0.013 (1.12)
P2 = 0.014/0.923 = 0.015 (1.13)
P3 = 0.897/0.923 = 0.972 (1.14)
So over 97% of infections a man causes are transmitted when he is in stage 3
(note that P1+P2+P3 = 1.0). Recall this is assuming that almost all partners are
susceptibles, but it also holds when the fraction of partners that are susceptible
remains constant, as when the epidemic is in equilibrium in the population. The
often repeated assertion that the primary stage plays the most significant role in
driving an HIV epidemic holds only when the epidemic is growing very rapidly
such as it did in San Francisco before 1981.
The mean transmission time: When a person is infected, we refer to the
“transmission time” as the length of time the infecter was infected at that point
in time. For example if someone is infected by a person in his/her primary stage,
the transmission time would be about 0.25 years on the average while if the
infecter was in stage 2 or 3, the transmission time would be about 4.0 or 9.0
years respectively on the average, the times from initial infections to the middles
of the stages.
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When an epidemic is at equilibrium the mean transmission time is computed
by weighting these three times by the fraction of people infected in that stage.
(P1 ∗ .25 + P2 ∗ 4.0 + P3 ∗ 9.0) = 8.81years (1.15)
If the epidemic is not at equilibrium but is growing, then there are two pos-
sible patterns. In the first pattern there will be relatively more people who were
recently infected than infected longer ago. In a growing epidemic, when a sus-
ceptible finally meets an infected person, that person is more likely to be in the
primary stage, as happened in San Francisco prior to 1981 (Figure 1.9). A more
precise calculation would take into account the exponential rate at which the
epidemic is growing. In the second pattern the majority of people come from
those in the third stage. The second pattern characterized San Francisco after
1981 (1981-1985) and Sub-Saharan Africa throughout their course.
Sub-Saharan Africa: Estimating mean transmission times allow us to extend
our findings to Sub-Saharan Africa and other heterosexual populations. It is
not known when the first case of HIV occurred in Africa, but it is believed to
have been around 1950 or perhaps earlier [36]. From 1950 to 1990, less than
1% of the population was infected as the number of cases went from 1 to about
1,000,000 producing a slow transmission wave [37, 38, 39]. We estimate the mean
transmission time about T = 7.44 years based on our values of infectivities when
an epidemic grows by a factor of 1,000,000 in 40 years. We now can estimate how
difficult it would be to stop the epidemic: R0 is defined to be the average number
of secondary cases caused by an average infected individual at the beginning of
the epidemic when almost all are susceptible. Stopping the epidemic quickly
requires interventions that result in driving R0 well below 1. Let the number of
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generations G = 40/T 5.4. If the epidemic grows by a factor R0 for each of G
generations the compound growth is R0
G which should equal about 1,000,000.
Our estimate that T = 7.44 yields R0 = 13. This calculation depends on the
infectivities and duration of the stages and not on other aspects of our SFCCC
model.
If an epidemiologist assumes the epidemic started, say in 1930, the argument
changes, yielding R0 = 4.3, but still remains well above 1. In either case, major
sociological changes are necessary to drive R0 below 1. If the epidemiologist was
not aware of the importance of the symptomatic stage and assumed that the
epidemic was driven by the primary stage, the mean transmission time would
be short. For the sake of argument we take it to be 1 year. Then there are 40
generations and R0 would be 1.4. This incorrect assumption would lead to an
underestimation of the severity of the epidemic. Only relatively small changes
would be necessary to bring R0 below 1, stopping the growth of the epidemic.
We remark for San Francisco a reduction of the effective contact rate by a
factor of 101 would have been necessary to prevent the epidemic from growing
early on in the epidemic (Figure 1.10). In other words, R0 was 101 for SFCCC.
1.5 Methodological Discussion of Modeling As-
sumptions
We want to know whether our results are artifacts of our modeling assumptions.
In this section we discuss our preferred use of six activity groups in our modeling
rather than the two or one activity groups used other researchers; the tacit as-
sumption of persisting levels of sexual activity; random mixing on the bathhouse
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Figure 1.10: Equilibrium Levels. At any average annual contact rate, over time,
an epidemic will stabilize at some fraction of the population infected. What this
equilibrium level is depends on the average annual number of contacts. The graph
displays equilibrium levels ranging from the SFCCC (F = 1), to contact rates
1/100th of the SFCCC (F = 100). Whenever F < 101 the equilibrium results
in some portion of the population infected, thus R0 = 101. The SFCCC peak is
70.2% where as the equilibrium level is 50%.
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assumption; and the use of deterministic rather than stochastic models.
Six-Group Model Assumption: Earlier variable-infectivity models [8, 6, 17, 18,
26, 40, 41] used at most two activity levels instead of our six. Core vs. non-core
models capture the importance of primary-stage infectivity in initiating the gay
epidemic but underestimate and thereby miss the critical role of symptomatic-
stage infectivity in sustaining and intensifying the gay epidemic after 1980 and
in initiating and sustaining slow transmission epidemics, such as Sub-Saharan
Africa. We compared our six-group assumption by making new optimization fits
to the SFCCC incidence curves using two-group and one-group models.
We use the 6-group model because it maximally utilizes the available contact
data. What happens if we use simplifying assumptions that do not take full
advantage of these data? The major difficulty of a two-group model is choosing
the number of contacts for each of the groups. The infectivities will depend upon
the level of activity of the two groups. Even if the first group (the core) is 10%
of the population it is unclear how to choose a single average number of contacts
for the remaining 90% of the population. Consider a two-group core/non core
model with non-core members having 27 contacts per year (two-group model A
in Table 1.3/Figure 1.11), the actual numerical average. Note that this average
includes group 6 whose members have no contacts. Surely, they should not be
included, but group 5 has almost no contacts (3 per year) and they have almost
no effect on the epidemic. Probably they should not be included. Group 4 has
15 contacts per year, enough to be significantly important in the epidemic, but it
plays much less of a role than groups 2 and 3 with 81 and 33 contacts per year.
Our two-group model B instead uses a weighted average to obtain a non core
average number of contacts of 53 per year, weighting the groups in proportion
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Figure 1.11: Comparison of our 6, 2 and 1-group model. The one-group model
cannot account for the initial growth of the epidemic. The six-group model has
the smallest RMS-error and gives the best-fit to the SFCCC data points.
to the number of contacts they have. In fact, neither model A nor model B is
perfect, which emphasizes the need for six groups, reflecting the SFCCC survey
data.
Changing our model to two-group model A yields 0.024, 0.005, 0.091 optimized
infectivities for primary, asymptomatic, and symptomatic stages – resulting in
an underestimate of symptomatic-stage infectivity by about 2/3. (This is in
keeping with results in prior two-group studies.) Two-group model B results in
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0.028 0 0.089 0.037
One-Group
Model
48 0.042 0 0.088 0.035
Table 1.3: Comparison of our Six-Group, Two-Group and One-Group Models.
It follows from the equations for each of these models that if all the contacts per
year are changed by a fixed factor, for example doubled, then all the infectivities
are reduced by that factor, i.e. cut in half. The one-group model produces
epidemics that always severely disagree with the San Francisco data and cannot
explain slow epidemics such as the African one. Both the two-group and the
one-group models underestimate symptomatic stage and thereby cannot explain
slow epidemics such as the African one.
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optimized infectivities of (0.028, 0.0, 0.089). Once again, the symptomatic stage
is underestimated by about 2/3.
Similarly, if we collapse all six activity groups into a single average activity
level, then in the best optimized one-group model the symptomatic stage is un-
derestimated (0.045, 0.000, 0.088). The goodness-of-fit error is 0.03 compared
to 0.016 for our six-group optimization fit. Even with high symptomatic-stage
infectivities a one-group model is unable to capture the beginning of the San
Francisco epidemic prior to 1979 (Figure 1.11). Details about the comparisons
between the different group optimized models are given in Table 1.3.
What these comparisons show is that using fewer than six activity groups
increasingly makes infectivity estimates be artifacts of the simplifying assump-
tions such as core/non-core or a single activity group used in prior modeling.
The six activity-group models reflect the diversity of the population and reflect
the reported data. What they teach us is that late in the disease, when more
than half of the population is infected, lower sexual activity groups are being in-
fected but the epidemic is accelerating. The SFCCC data show large numbers of
persons become infected, but there are fewer contacts with susceptibles because
those still susceptible have few contacts. Most of these infections result from
partners in the symptomatic stage. This requires a higher symptomatic-stage
infectivity estimate than previous models which failed to reflect the low activity
of remaining susceptibles. After 1980 the gay epidemic becomes dominated by
symptomatic-stage transmission.
Constant Sexual Activity Levels Assumption: The data we use is from the
San Francisco epidemic up to 1984. We have assumed that each individual has
a sexual activity level that does not change significantly over the period we are
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modeling. The Bell-Weinberg study [42], a Kinsey Institute study of the 1969
San Francisco Population, found that the most active 28% of men had 51 or more
partners “in the past year”. The study also found that the men who were most
active over their lifetimes (again 28%) had 1000 or more partners (see Table 1.4).
Such a total requires many years of high activity levels-perhaps one or two decades
or longer. Our model is appropriate for such a population. Of course there will
be some individuals who change behavior but a large fraction of the most active
”core” population will remain highly active when they are in the symptomatic
stage. The epidemic went from 4.5% infected to 60% in just 5 years.
One can hypothesize populations with variable activity levels. Some earlier
models assume that individuals vary in their activity level over time. For example,
Koopman et al. [26] assume this variation is quite rapid. They use two activity
levels: a core with 5% of the population and the less active non-core. They assume
that individuals remain in the core for an average of one year, saying, “Our models
are not intended to reflect the transmission dynamics of any real population”
([26], page 250). The assumption implies there is virtually no correlation between
the activity level of a man when he becomes infected and the activity level a few
years later when he is in the symptomatic stage. (Under that assumption, the
probability of an individual in the core will remain in the core for say 6 years is
exp−6 or ∼ 1/400). Having people rapidly switch activity levels is quite similar
to assuming there is a single activity level.
Some may suggest, quite plausibly, that it is likely people in the symptomatic
stage are less active due to effect of HIV. If so, then the symptomatic-stage
infectivity would have to be higher than our .299, to account for the large number




% Number of Homosex-
ual Partners in Past
Year
%
1 0 0 3
2 0 1-2 8
1-2 1 3-5 10
3-4 2 6-10 12
5-9 3 11-19 12
10-14 3 20-50 27







Table 1.4: Bell- Weinburg Survey of 572 Homosexual Men in San Francisco in
1969 [42].
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cut the number of contacts in half uniformly, for the symptomatic stage and
for all activity groups, then the optimal symptomatic-stage infectivity would be
doubled in order not to decrease the number of new infections below the observed
level.
In order to account for the large number of new infections in the latter stage
of the epidemic, where most of the susceptibles were from low activity groups,
one must have high symptomatic-stage infectivity. Only the six-group models
are able to determine the high level of infectivity in the symptomatic stage.
Model Assumes no Decrease in Activity as the Epidemic Explodes: What if
activity levels dropped as the epidemic progressed? It is likely that activity levels
began to drop as people became aware of some new gay disease around 1984 or
1985 [8]. We have tried alternatives to our model, for example, by cutting the
contact rate in half in 1983-1984. We then again determine the infectivities for
the three stages that result in the best fit of the data. The main effect is that the
symptomatic-stage infectivity must be higher than in our standard model. The
infectivities of the first two stages are largely determined by the need to fit the pre-
1981 beginning of the epidemic when there are very few symptomatic-stage men.
Decreasing the activity while maintaining the number infected results in higher
symptomatic infectivity. Our main conclusion in this dissertation is that the
symptomatic stage is far more infectious than the earlier stages. Our conclusion
remains valid when there is a decrease in sexual activity level as the epidemic
progresses. Our symptomatic-stage estimate, although higher than what prior
studies report [8, 18, 26], is in fact a lower bound. Indeed, Hethcote and Van
Ark’s assumption of decrease activity beginning in 1981 requires them to use an
AIDS-stage infectivity of 0.75 to model the SFCCC data [6].
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Model Without Age Structure: The bathhouse assumption supposes casual
promiscuous gay sex with random mating. The Bell-Weinberg data (Table 1.4)
suggest the bathhouse assumption is appropriate for this population. However,
some researchers have hypothesized that random mating is inappropriate on the
assumption that people prefer to partner with persons close to their own age.
We do not employ such an age-preferred model (in which partners are selected
based in part on their ages) because the data do not support one. Koopman et al.
[26] considered an age-preferred model with eight 2-year age groups. Their “age-
preferred” mixing pattern assumes 80% of partnerships are reserved for one’s own
age group and the other 20% are the result of proportionate mixing independent
of age. This pattern however is difficult to achieve: for example, assume that
people’s ages are uniformly distributed within each age group and that the age of
a person’s partners is normally distributed with the mean equal to the person’s
age. For a person to have 80% of his partners within his own age group (under the
Koopman et al assumption of 2-year age groups) then on average the standard
deviation would be about 0.5 years. Under the best of conditions it would be
extremely unlikely that people would be able to estimate someone’s age within
0.5 years. In the SFCCC the majority of sexual contacts were between men
who were strangers and one-time partners [42, 43, 44, 45]. A disproportionate
fraction of the core contacts occurred in bathhouse orgy rooms, which typically
were virtually dark. It is extremely difficult to make gross distinctions of age in
the dark. Making a half-year distinctions seem impossible. Even if we considered
an age-preferred model with age groups of 5 years, the standard deviation would
be approximately 1.3, still extremely unrealistic for the San Francisco population.
Stochastic versus Deterministic Models: Our model is a deterministic model.
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At each time step we determine the fraction of individuals who transition from one
stage of infection to the next for each activity level, such as from core susceptible
to core primary infection. We also developed a stochastic model where at each
time step we first compute the fraction of people who would make each transition
according to the rules of our deterministic model and convert this to a number
of men by considering the late 70s-early 80s San Francisco gay population to be
an estimated 70,000 individuals [31]. Using this fraction as a mean, we select a
random number from a Poisson distribution. This random number becomes the
number of individuals who make the transition at that time. The epidemic is
then simulated repeating this Poisson process for each time step and for every
transition (See Appendix C for stochastic model equations). We find the biggest
differences between the epidemics of the deterministic model and the stochastic
model occur when the fraction of people infected is very small. By the time the
fraction infected reaches 4.5% (as was the case in 1978, the SFCCC first data
point) both models generate very similar curves.
Since we are using the same three infectivities in both models our confidence
in these three infectivities increases: When their results are congruent, there is
negligible harm in using a deterministic model even when a stochastic model
theoretically might seem more appropriate. Both approaches require high levels
of symptomatic-stage infectivity compared to primary-stage infectivity.
We conclude that, compared with the assumptions used by other researchers,
ours are more realistic and/or appropriate when applied to the SFCCC popu-
lation. Our finding that symptomatic-stage infectivities are about thirty-times
higher than previous estimates is not an artifact of our assumptions.
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1.6 Discussion of Modeling Conclusions
Testing the conclusion symptomatic infectivity is greater than primary infectivity:
To further test this conclusion we examine the cases where the two infectivities are
equal. For comparison we ran our optimization code with the added constraint
that the primary-stage infectivity equals the symptomatic-stage infectivity. The
“best-fit” infectivities are 0.0, 0.02, 0.0 respectively for the three stages and the
RMS error is 0.036. Note the RMS is more than twice the RMS error for “best-
fit” infectivities mentioned previously. With this constraint there is no ”best-fit”
with positive values for the primary and symptomatic-stage infectivities.
Sensitivity analysis for SFCCC data: Although the SFCCC HIV incidence
data are unusually high resolution and biologically based, they still are subject
to measurement and sampling errors. By our estimate, the 4.5% prevalence figure
might better be reported as 4.5± 1.3 % representing a one standard deviation
error. The method for computing prevalence for other years is reported with less
detail and we cannot compute standard deviations for those years. Further the
behavioral data are self-reported. Studies indicate such self-reported behaviors
among gay men are quite reliable [43, 44, 45]. Nevertheless there are errors
inherent in such data.
When we vary the fraction of population that is infected for the data points
1978 through 1984 by about 0.02 and then apply the above optimization pro-
cedure, we get slightly different infectivities for our three stages. In summary,
primary-stage infectivity varies in the range 2.3-2.5%, asymptomatic from 0.0-
0.4%, and symptomatic/AIDS from 25.4-34.4%. Figure 1.12 shows us the region
of uncertainty.
Interval of Infectivity Estimates: Our infectivity results must be valid for
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Figure 1.12: Sensitivity Analysis. The three infectivities for our three stages
depend on the reported epidemic data for years 1978 through 1984. There is an
inherent error in the data, perhaps 1-2%. If these data points are changed by a
(root-mean-square) average of 2%, the infectivities lie on the ellipsoid shown. If
they are changed by 4% the size of the ellipse will be doubled in each direction.
If they are not changed, they lie at the center of the ellipsoid.
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variations in model parameters4. Earlier we discussed error in the data points
and the effect that variations in the data would have on our infectivity results.
We also mentioned the differences between stochastic and deterministic models.
Infectivities would increase if we considered a behavior change before 1985 due to
knowledge of the disease or associated with progression of the disease. We could
also take into account the possibility of preferential mixing, in which one chooses
partners within their own group. If one does not allow those in lower activity
groups to have contacts with those in the core and other more active groups, then
in order for the epidemic to rip through the six groups as shown in Figure 1.5,
the third-stage infectivity would have to be even higher than our estimates. This
conclusion holds when one considers a combination of the bathhouse mixing and
preferential mixing.
Allowing all combinations of parameters mentioned above, we end up with
intervals of infectivity estimates. The primary stage varies within (0.014-0.024),
the asymptomatic (0.000- 0.008)5, and the symptomatic (0.126-0.493). We are
interested in the ratio of the symptomatic-stage infectivity to the primary-stage
infectivity, which varies (8.6-33.7). So we conclude that even under variations of
our model parameters the symptomatic stage remains significantly more infec-
tious than the primary stage.
4Our model has a time step of 1/4 of a year, 2 sub-stages for the primary period, 3 sub-stages
for the asymptomatic period, and one for the symptomatic period. We also considered time
steps of 1/3 and of a year, along with 1-2 sub-stages for primary, 1-6 for asymptomatic and
1-2 for symptomatic.
5If in our optimization routine an infectivity value becomes negative, we set it to zero. We
do not believe that the asymptomatic period is ever truly zero.
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1.7 Conclusion:
Earlier models shed little light on slow-transmission epidemics such as the African
and the San Francisco epidemic from 1980. They are dominated by symptomatic-
stage transmission. In addition, they seriously distort the transmission dynamics
after 1980: In two-wave epidemics, such as the San Francisco gay one, there
is a period when primary-infection stage transmission is the predominant mode
of transmission and alone can sustain the epidemic. Only symptomatic-stage
infection can sustain a slow epidemic as in Africa. If there is no such period
you get an epidemic such as the South African one. Ultimately both epidemic
patterns become dominated by symptomatic-stage transmission.
Underestimating the symptomatic-stage infectivity results in a severe under-
estimation of R0, the severity of the epidemic, and the measures necessary to end
the epidemic. Our results provide a firm basis for a needed systematic reassess-
ment of prevailing wisdom and strategies concerning the control, containment,
and management of the HIV pandemic. Our results imply that screening of at
risk populations can identify most infected individuals before they enter their
most infectious stage. Removal of symptomatic-stage transmission would reduce




A Risk Based Model for HIV
2.1 Introduction
Previous models of HIV [8, 6, 17, 18] are compartment based. The compartments
represent stages of HIV infection. A person is expected to pass through the
stages sequentially as the virus becomes more dominant within the person’s body.
Those models assume that the time it takes an infected person to pass through a
stage is a random variable that is exponentially distributed [6, 46] and that the
infectiousness of an individual varies by stage of infection and each stage has its
own level of infectiousness. One can derive from such models an ”infectiousness
distribution” that tells how infectious the average person is time τ after initial
infection.
The models we present here omit the stages and assumes the infectiousness
distribution of an infected man is specified independently of the model. Our
approach to creating the models in this chapter focuses on a susceptible person’s
risk of becoming infected if he has a single contact with an infected individual.
The dynamics of traditional models instead are based on number of new infections
per unit time. This difference allows us to build a scalar model representing
40
Figure 2.1: HIV stages [9] and infectiousness. A susceptible becomes newly
infected and progresses from a primary infection stage through an asymptomatic
stage into a symptomatic stage followed by death. Infectiousness varies greatly
from stage to stage.
populations with many different sub-groups. Our equation is an integral equation
rather than a differential equation. That allows greater freedom in choosing the
distribution of infectiousness. To introduce the ideas of our models we begin by
creating a model for a homogeneous population. Then we develop our full model
in which there is an arbitrary number of groups that have varying levels of sexual
activity.
2.2 Infectiousness Distribution
The infectiousness of a person is the probability that a contact with a susceptible
will result in that person becoming infected. A susceptible can only become
infected through such a contact. Previous models, including ours from Chapter
one, are compartment models with individuals changing their infectiousness as
they change stage of disease. Our model has 3 stages, primary, asymptomatic
and symptomatic (Figure 2.1).
We have an infectiousness associated with each stage of infection, 0.024, 0.002
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and 0.299 respectively. We call these infectivities our “best-fit” infectivities 1 see
Figure 2.2. The motivation behind our new model is to be able to put any curve
describing infectivity into our model.
We define infectiousness as a piecewise continuous function I : [0,∞] → [0, 1]
which is the expected infectiousness after a person is infected at time τ . As an
example, if we assume the infectiousness, I0, is constant in each of three stages
and the progression from each stage to the next is as described in Chapter 1,
then as an average person progresses through the disease their infectiousness




Pk(τ) ∗ Pkinfec (2.1)
Where Pk(τ) is the probability a person infected for time τ is in stage k and
Pkinfec is the infectivity per contact for the k
th stage. For our three-stage model
the stages are primary, asymptomatic and symptomatic with the infectivities
equal to our best-fit infectivities mentioned above.
We obtain the infectiousness distribution in Figure 2.3 by running our model
with the three best-fit infectivities. We allow for one individual to be infected
and follow his expected infectiousness as defined by equation 2.1. Note that
in the beginning of the epidemic the individual is in the primary stage with
probability 1 and thus has an infectiousness of 0.024. The infectiousness drops as
1The infectivities are obtained from a difference equation model, described in Chapter 1,
that finds the three infectivities that best-fit the SFCCC (San Francisco City Clinic Cohort)
epidemic. The SFCCC epidemic is based on data collected from gay men that participated in
a hepatitis B vaccination trial study from 1978 through 1984. Blood samples and survey data
were collected from nearly 7,000 men. The blood samples were frozen and through analysis
of these blood samples the number of HIV cases in the gay population in San Francisco were
obtained.
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Figure 2.2: Best-fit Infectivity Distribution: Our model described in Chapter 1
solves for the three infectivities that best-fit the SFCCC epidemic. Those infec-
tivities are 0.024, 0.002, 0.299 for the primary, asymptomatic and symptomatic
stages respectively. An average individual is in the primary stage for 0.5 years,
the asymptomatic stage 7 years and the symptomatic stage for 3 years. This
figure shows the average infectiousness of a fictitious person who passes through
each stage at precisely the expected time
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Figure 2.3: Continuous distribution of infectiousness averaged over the popula-
tion, I0(τ) (Equation (2.1)).
the individual moves into the asymptomatic period, then peaks as the probability
they have transitioned into the symptomatic stage increases. The infectiousness
begins to decrease as the probability of death increases.
2.3 Risk Model and Assumptions
Assumptions
1. After time t0, no one enters or leaves the population.
Our goal is to model an HIV outbreak over a fairly short period of time
beginning at time t0. In fact a very small fraction will die, but, we treat
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these as people whose infectiousness is zero. This approach has negligible
impact on the transmission dynamics as long as the fraction that is dead is
small. This assumption has the effect of lowering the contact rate slightly
as people die.
2. Each individual has a contact rate that is independent of t.
In section 2.4 we will assume all individuals have the same contact rate and
in section 2.5 we assume the rates vary from person to person.
3. Mixing Assumption The probability of 2 people having a contact is in-
dependent of disease status (infected or susceptible) or stage.
4. Infectiousness is independent of the person’s contact rate.
5. All susceptibles are equally susceptible.
There is a risk function, R(t), the probability that any susceptible who has a





Note: dA/dt = R(t). Time t = t0 denotes the beginning of the outbreak.
2.4 One-Group Risk Model
We create a model in this section that focuses on a susceptible person’s risk of
becoming infected if they have a single contact with an average infected individ-
ual. We will assume that we are dealing with a homogeneous population; there
is one activity group for the given population.
6. Assume all individuals have the same number of contacts per unit time C.
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7. External Risk Assumption We assume that prior to time t0, the risk
is 0, and at time t0 a transient infected individual is momentarily present and
making contacts. We treat this event by assuming R is a δ-function at t0 with
weight a, so limε→0
∫ ε+t0
−ε+t0 R(s)ds = a.







−∞ I(τ)R(t− τ)C exp (−CA(t− τ))dτ for t > t0










S(t) = −CR(t)S(t) (2.5)
and
S(t) = exp (−CA(t)) (2.6)
A susceptible person having a contact at time t has a chance of being infected
by a person who in turn was infected during the interval J = [t−τ, t−τ +dτ ]. We
treat the length of the interval as an infinitesimal. So we need to know how many
such people were infected during J . The fraction of the population susceptible
at time t− τ is
S(t− τ) = exp (−CA(t− τ)) (2.7)
The fraction of the population that is susceptible and has a contact during J is
CS(t− τ)dτ (2.8)
46
Hence, the fraction of the population infected during J is
R(t− τ)CS(t− τ)dτ (2.9)
If I(τ) is the expected average infectiousness, as defined above, of someone in-
fected for time τ , then the risk due to individuals infected during J is
I(τ)R(t− τ)CS(t− τ)dτ (2.10)
Note: there is an additional external risk (assumption 7) of magnitude aδ(t− t0).
Integrating from −∞ to t and adding the external risk gives the risk due to all
individuals infected up to time t
R(t) = aδ(t− t0) +
∫ t
−∞
I(τ)R(t− τ)CS(t− τ)dτ (2.11)
which is equivalent to Equation (2.3), by using Equation (2.7).
2.5 Multiple-Group Risk Model
Let G denote the number of activity groups.
8. We assume now that the number of activity groups is finite and bigger
than 1.
We will include the case with an infinite number of groups by converting a sum
over the activity groups to a Riemann-Stieltjes integral. Let Cj denote the num-
ber of contacts a person in group j has per unit time and Fj be the fraction of
the population in group j. We claim that R(t),the probability of a susceptible
becoming infected from one contact per time unit with group j at time t is
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j BjCjSj(t− τ)dτ for t > t0






Write Sj(t) for the fraction of group j that is susceptible. Then
dSj/dt = −CjR(t)Sj (2.14)
It follows that at time t− τ ,
Sj(t− τ) = exp (−CjA(t− τ)) (2.15)
The number of contacts the susceptible population has with group j in J is
CjSj(t− τ))dτ (2.16)
If the person contacted someone from group j, then the probability that person
was infected during J is
R(t− τ)CjSj(t− τ))dτ (2.17)
From the mixing assumption (assumption 3) if a person has one contact, the







j Bj = 1.










If I(τ) is the expected average infectiousness, as defined above, of someone in-












Adding the external risk aδ(t − t0) gives a total that is equivalent to Equation
(2.12), by using Equation (2.15).
2.6 Infinitely Many Activity Groups:
From the SFCCC data we obtain 6 different activity level groups (Table 1.2),
creating a step function contact rate distribution (Figure 2.4). We can view
these levels or groups as an average, in reality there is a range within each group.
For example, the core group (the most active group) consisted of 10% of the
population with an average of 231 partners per year. Within this 10% there
are those individuals who had less than 231 and those who had more. We can
consider a continuous distribution that describes the population’s activity levels.
The mean value of the curve from 0%-10% would be 231, the average number
of contacts in the core group. Similarly, the mean value of the curve from 10%
to 25% would be 81, the average number of contacts for group 2, etc. Instead
of considering 6 activity groups, we can consider an infinite number. Figure 2.5
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gives an example of such a continuous contact distribution. Just as it would be
an error to treat all individuals as having the average number of contacts, it is
also an error, tho smaller, to assume there are six groups. The more groups, the
less error. We now create a new model that not only allows for any infectivity
distribution, but also any contact rate distribution.
Reimann-Stieltjes Integral: Let F (C) be the fraction of the population with






Let B(C) be the fraction of all contacts that are with contact rate ≥ C. Then if
there are a finite number of groups Bj becomes B(C) where,







The risk function (including the external risk) becomes






C exp (−CA(t− τ))dB(C)dτ (2.25)
2.7 Numerical Solution







I(τ)Rδ(t− τ − δ)
∫∞
0
C exp (−CAδ(t− τ − δ))dB(C)dτ if t > t0 + δ







Aδ(t0) = 0 and 0 < δ ¿ 1. We can solve Equation (2.26) incrementally on
intervals Jn = [nδ, (n + 1)δ]. For t ∈ Jn, Rδ(t) depends only on Rδ and Aδ for
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Figure 2.4: SFCCC activity levels distribution. The SFCCC reports annual
numbers of partners for six different activity levels [8, 6]. Published survey data
(Table 1.2, column 3) gives the distribution of the number of partners for six
activity levels. The top 10% of the population “the core” has an average 231
partners per year, the next 15% of the population has an average of 81 partners
per year, etc.
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Figure 2.5: Continuous distribution describing activity levels. The mean value
of the top 10% of the population has an average of 231 partners per year. This
corresponds to the SFCCC survey data. The mean value of the next 15% of the
population has an average of 81 partners per year, corresponding to group 2 of
the SFCCC survey data.
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t ∈ [t0, nδ]. We use this approximation in practice with a variety of steps down
to δ = 1/364 years.
2.8 The Distribution Problem:
Distribution problems concern allocating the relative contributions of various
sources to some aggregate measure. Our distribution problem concerns partition-
ing the total susceptibles in the population at time t among all the activity-level
groups. Many data sets have the total fraction of the population susceptible at
time t, but does not allocate that fraction among the different activity levels
within that population. Let G denote the number of activity groups. The case of
six groups was discussed in Chapter 1, where we use a system of difference equa-
tions to show how the disease propagated through the subpopulations. Below is
an alternative way of deriving the curves in Figure 1.5.
Let Sj(0) = 1 (the beginning of the epidemic) where Sj(t) is the susceptible
fraction of group j at time t. Write S ′j for dSj/dt. Then
S ′j/Sj = R(t)Cj (2.28)
Then
ln Sj(t) = −Cj
∫ t
0
R(t) = −CjA(t) (2.29)
thus,
Sj(t) = exp (−CjA(t)) (2.30)
Equivalently,
Sj(t)
1/Cj = exp (−A(t)) (2.31)
It follows that,
Sj(t) = S1(t)Cj/C1 (2.32)
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Group I (4) Fraction Sj = S1Cj/C1 susceptible where
S1 = 0.5 S1 = 0.1 S1 = 0.02
1 (”Core”) .500 .100 .020
2 .784 .448 .254
3 .906 .720 .572
4 .956 .861 .776
5 .991 .971 .950
6 1.000 1.000 1.000
Total Pop .882 .718 .620
Table 2.1: Group susceptible fractions (solution to distribution problem) when
G = 6 and number of contacts for the six groups are defined by the SFCCC data
(Table 1.2).
We use this fact in Table 2.1, Columns 2-4, where we look at the case of SFCCC
data where G = 6 and the activity levels are defined by Table 1.2.
Initially at the beginning of the epidemic, t = 0, we have A(0) = 0, the
accumulated risk function, and from then on A(t) increases, therefore exp (−A(t))
starts at 1 and decreases.
The fraction of the population susceptible is the sum of the susceptibles in each





Fj exp (−CjA(t)) (2.33)
Ignoring t we can plot S as a function of exp (−A) between 0 and 1 (Figure 2.6),
and we obtain an increasing curve, which can be used to solve for A given any
value of S between 0 and 1. Knowing A means we know each Sj by Equation
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Figure 2.6: Plot of S(t) =
∑
Fj exp (−CjA) varying exp (−A) between 0 and 1.
2.30. Thus, from the total fraction of the population susceptible we are able to
distribute them among G groups. If F ∗j denotes the fraction of the people that
are in the bathhouse who are from group j, then





































1979 90.70% 74% 173 0%** 0 0.01 0 indet.
1980 79.90% 50.50% 225 0.10% 0.5 0.01 0 indet.
1981 71.20% 35% 204 0.80% 2.5 0.005 0 indet
1982 60% 23% 159 2.80% 5.8 0.02 1.63 ≥ 28%
1983 46% 11.80% 94 6.60% 7 0.025 1.36 ≥ 19%
1984 35% 6% 51 12% 6.5 0.032 1.1 ≥ 17%
Table 2.2: 900 Men in bathhouse on a given day *The susceptible % of the
population (Column 2) are mid-year averages from Table 1.1, Column 2, ** 1/6
person or less. ***Excess cases are new cases per day in excess of 1% infectivity.
See Appendix D for details
infectivities are used.
2.9 Conclusion
We have derived a new risk model that allows for any distribution of infectiousness
and an infinite number of activity level groups. Our original model, described
in Chapter 1, had three levels of infectiousness corresponding to the primary,
asymptomatic and symptomatic stage and the six activity levels from the SFCCC
survey data. This new risk model allows much more flexibility for determining
information about an infectious disease.
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Appendix A
The Fraction of Infecteds in the Bathhouse by Activity
Group
From the model equations we calculate the proportion of infected in each activity
group verses time as follows:
Ii
t = 2 ∗ Pit + L1,it + L2,it + L3,it + Ait (A.1)




The model’s bookkeeping of new infections in one time step: Given the fraction
in each stage of each activity group, the model computes the expected number
of contacts for all of the men in each of the four stages (suscepible, primary,
asymptomatic and symptomatic), Nsus, Np, Na, andNs. Let Ip, Ia, Is be the infec-
tiousness per contact for the stage. The risk R of a susceptible man becoming
infected from one contact is:
R = (Ip ∗Np + Ia ∗Na + Is ∗Ns)/(Nsus + Np + Na + Ns) (B.1)
In each activity group, the fraction of men newly infected Fnew at time t+∆t
is the fraction susceptible times the number of contacts each has in time ∆t times
the risk R. To obtain the susceptible population for each activity group for the
time t + ∆t, we subtract the fraction Fnew from the susceptible fraction for time
t, and we add Fnew to the primary stage for time t + ∆t.
The model’s bookkeeping of the fraction in each stage: If the average duration
for a stage is Y years, then the fraction ∆t/Y of people in that stage are moved
to the next stage. We use 2∆t years for the duration of primary stage, 7 years
for asymptomatic, 3 years for symptomatic. Note on primary duration: The real
meaning of the 2∆t year primary period (which seems rather long to us) is that
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people for are initially infected at time t can create new infections at time t + ∆t
and the number of contacts they have while in primary stage is 2∆t times the
number of contacts for a year. One could alternatively say the primary period is




As mentioned above, we developed a stochastic model where at each time step we
first compute the fraction of people who would make each transition according
to the rules of our deterministic model and convert this to a number of men
by considering the late 70s-early 80s San Francisco gay population to be an
estimated 70,000 individuals [31]. Using this fraction as a mean, we select a
random number from a Poisson distribution. This random number becomes the
number of individuals who make the transition at that time. The epidemic is
then simulated repeating this Poisson process for each time step and for every
transition.
Let fi = the fraction of population in activity group i, T =total population
(70, 000)
Stochastic Model
1. (a) Ptranst+11,i = P
t
1,i Fraction that transition from P1 to P2 at time t
(b) Let λ = P t1,iT
(c) Compute random variable from 0 to 1, r








(f) Let Ptranst+11,i = N/fi/T
2. Repeat procedure for:
(a) Ptranst+12,i = P
t














∆t Fraction that transition from L3 to A at time
t
(e) Atranst+1 = A
t
3





Lower-bound stage infectivity estimates: We can estimate infectivity by simply
assuming that symptomatic-stage HIV infectivity differs from that for primary-
infection and asymptomatic stages-that is, that there are only two stage-level
infectivities. In the early years of the epidemic (up through 1980), transmis-
sion was almost exclusively by primary stage men. Figure 1.4 shows negligible
symptomatic-stage men in the bathhouse up through 1980 when 73.8% of the
population was susceptible.
The susceptible % in the bathhouse (Column 3) is from the solution to the
distribution problem as described above in Chapter 2. The number of contacts
between susceptibles and infecteds (Column 4) is the product of the number of
susceptibles among the 900 men1, (Column 3) × 900, and the infected proportion
(100% - Column 3). For example, in 1982 when 23% were susceptible, there were
159 contacts between susceptibles and infecteds (= 23% × 900 × (100% - 23%)).
The symptomatic % in the bathhouse (Column 5) is the % of the population
symptomatic at mid-year (Table 1.1 Column 5) times 2.5, where 2.5 is from the
1On a typical night in 1980 approximately 900 members of the SFCCC cohort were in the
bathhouse.
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inverse problem solution as described above. The contacts between susceptibles
and symptomatics in the bathhouse (Column 6) is the fraction of contacts between
susceptibles and infecteds that involve symptomatics (= Column 4 × Column 5).
For example, in 1982 when 2.8% of the men in the bathhouse were symptomatic
and there were 159 contacts between susceptibles and infecteds, there were 5.8
contacts between susceptibles and symptomatics (= 159 × 2.8%).
The Number of new cases per contact between a susceptible and an infected
(Column 7), which equals the number of new cases per day, is the average number
of men infected daily during the year [= (Table 1.1 Column 3 6875 men)/365
days] divided by the number of daily contacts between susceptibles and infecteds
(Column 4). For example, in 1982 there were an average of 3.22 new infections
daily [(17.1% × 6875)/365] divided by 159 susceptible-infected contacts daily
which equals 0.02 new cases per susceptible-infected contact.
We estimate symptomatic-stage infectivity (Column 9) on the basis of the
excess that cannot be attributed to primary-stage transmission (Column 8). The
first symptomatic AIDS cases occur in 1980. We assume that prior to 1980 pre-
symptomatic (primary and asymptomatic) stage men transmitted HIV. Column
6 shows that risk being 1% per susceptible-infected contact. A lower-bound esti-
mate on symptomatic-stage transmission risks is obtained by allocating responsi-
bility for new infections between pre-symptomatic stage contacts at 1% risk and
assigning the excess to the symptomatic stage, and then solving for symptomatic-
stage transmission risks: The excess of new cases (Column 8) = New cases per
day [Column 7] - (0.01 number of susceptible-infected contacts [Column 4]). The
symptomatic-stage infectivity required to account for that excess [Column 9] =
(excess new cases [Column 8] ÷ number of susceptible-infected contacts [Column
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3]). For example, in 1982 we get 3.22 - (0.01 × 159) = 1.63 excess new cases
daily. So the infectivity required to account for those 1.63 excess new cases daily
is 163 ÷ 5.8 = 28%.
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